Caas Capital Management LP Procept Bio Robotics Corp Transaction History

Caas Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$16.89 - $35.74 $829,180 - $1.75 Million	-49,093 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.6 - $46.29 $22,312 - $41,985	-907 Reduced 1.81%	49,093 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $41.94 $1.8 Million - $2.1 Million	50,000 New	50,000 $1.91 Million

173

38.1M

386K

259K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.82B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.